Harel Insurance Investments & Financial Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,100	Closed	-$92K	–	730
2020 Q3	$92K	Buy	+1,100	New	+$92K	﹤0.01%	400